Bringing your pharmaceutical product to market is a complex process that requires navigating regulatory approvals, securing market access, establishing distribution networks, and driving product adoption among healthcare professionals. Without the right strategy, even the most promising therapies may struggle to reach the patients who need them.

Strategic partnerships provide a solution by enabling you to expand your reach efficiently and effectively. By working with experienced commercialisation partners, you can leverage their existing regulatory expertise, commercial infrastructure, and distribution networks. This allows for faster product launches, improved patient access, and long-term market sustainability.

Navigating Regulatory Strategy and Market Access

Securing regulatory approval is one of the most challenging and time-consuming steps in commercialisation. Each market has its own set of compliance requirements, making it difficult to navigate without specialised expertise. By working with a partner, you gain access to regulatory professionals who can streamline submission and approval processes, so your product meets country-specific requirements and gains market authorisation faster.

However, gaining market access involves more than just regulatory approval. Pricing approvals, formulary inclusion, and engagement with healthcare payers all determine whether your product will ultimately reach the patients that need it. Many pharmaceutical companies face challenges in securing reimbursement, which is where an experienced commercialisation partner can come in.

With an experienced partner, you have access to established networks of decision-makers, helping you position your product effectively within healthcare systems. Your partner can conduct health economic assessments, demonstrate the value of your therapy to payers, and negotiate reimbursement agreements on your behalf.

Expanding Your Geographic Footprint Through Established Distribution Channels

Expanding into new markets not only comes with regulatory compliance challenges but also logistical and distribution challenges. Working with an experienced partner with local expertise, an established market presence, and robust distribution networks helps overcome these challenges and reduces financial risks.

These licensing partnerships can help accelerate patient access to innovative therapies and strengthen your global footprint by streamlining logistics, optimising supply chain operations, and preventing delays in product availability. These partnerships also help you maintain compliance with Good Distribution Practice (GDP), safeguarding product integrity and enabling a consistent supply to healthcare providers.

Developing a Sales and Marketing Strategy That Drives Adoption

A strong sales and marketing strategy helps overcome barriers of market adoption. A strategic partnership provides the expertise needed to position your pharmaceutical product effectively in competitive markets. Your partner can support branding efforts, develop targeted marketing campaigns, and engage with key opinion leaders (KOLs) to enhance product awareness.

Additionally, your partner can help implement digital marketing strategies, train your salesforce, and build direct engagement with prescribers. By leveraging an experienced partner’s commercial expertise, you can strengthen your product’s visibility and accelerate prescription uptake.

Ensuring Long-Term Success with Pharmacovigilance and Post-Market Support

Ongoing pharmacovigilance and post-market surveillance are critical to maintaining regulatory compliance and ensuring patient safety. Partnering with an experienced pharmacovigilance partner provides you with robust pharmacovigilance support, helping you manage these post-market obligations effectively, helping to secure your product’s long-term success.

Galen & Italfarmaco

Galen Ltd entered into an exclusive licensing agreement with Italfarmaco to distribute a women’s health product in Ireland. Through this partnership, Galen was able to leverage its extensive commercial and distribution infrastructure to deliver a valuable solution for women's health.

Critically, Galen also played a pivotal role in facilitating the reimbursement of the medication within the Irish healthcare system. Historically, some women faced costs that could exceed €150 per month for this essential treatment. This financial burden significantly limited access to care for many women.

By working closely with healthcare payers and leveraging its deep understanding of the Irish market, Galen successfully secured full reimbursement for the product. This achievement not only enabled a successful launch but also ensured that the medication could be prescribed without cost barriers, dramatically improving equitable access to vital healthcare services for women across Ireland.

How the Right Licensing Partner Can Maximise Your Product’s Success

Strategic partnerships give you the resources and expertise needed to navigate the complexities of commercialisation. By working with an experienced partner, you gain access to regulatory support, market access capabilities, and established distribution networks, helping you reduce risks and accelerate product availability.

Contact us today to explore how licensing with an experienced partner like Galen can accelerate your product’s time to market and enhance patient access.